Core Viewpoint - The company, Steady Medical, is transitioning from product export to brand export, aiming to establish itself as a leading global health enterprise through high-quality products and operational excellence [1][9]. Company Development - Founded in 1991 by Li Jianquan, Steady Medical has evolved from a medical dressing exporter to a dual-driven health enterprise combining medical and consumer goods [1][4]. - The company initially focused on medical dressings, establishing its own brand "Winner Steady Medical" after starting as an OEM for foreign brands [4][6]. - In 2009, the company launched "Cotton Era," aiming to innovate from medical-grade products to consumer goods, despite facing initial losses of nearly 200 million yuan in the first four years [5][6]. Innovation and Product Quality - Steady Medical emphasizes product quality and innovation, having invested over 500 tons of cotton to develop a cotton-based non-woven fabric technology that simplifies production and addresses industry pain points [4][5]. - The company has established a dual business model of medical and consumer products, leveraging the same supply chain and technology standards for synergy [7][8]. Financial Performance - In the first half of 2025, Steady Medical achieved a revenue of 5.296 billion yuan, a year-on-year increase of 31.31%, with a net profit of 492 million yuan, up 28.07% [8]. - The medical segment generated 2.52 billion yuan in revenue, growing 46.4%, while the Cotton Era brand achieved 2.75 billion yuan, a 20.3% increase [8]. Global Expansion and M&A - The company is shifting towards brand export, highlighted by the acquisition of a 75.2% stake in the U.S. medical consumables company GRI for 120 million USD, which is expected to enhance its global strategy [9][10]. - In the first half of 2025, overseas sales reached 1.43 billion yuan, marking an 81.3% increase, with products sold in over 110 countries [9][10]. Future Strategy - Steady Medical plans to convert 90% of its overseas medical business to proprietary brands, moving away from OEM production, while Cotton Era will focus on establishing a strong domestic presence before expanding internationally [10].

Core Viewpoint - The company, Steady Medical, is transitioning from product export to brand export, aiming to establish itself as a leading global health enterprise through high-quality products and operational excellence [1][4][6]. Group 1: Company History and Development - Founded in 1991 by Li Jianquan, Steady Medical initially focused on medical dressings and later launched the consumer brand "Cotton Era" in 2009, marking its entry into the consumer goods market [1][2]. - The company faced significant challenges in its early years, including nearly 200 million yuan in cumulative losses over the first four years of Cotton Era's establishment, due to high costs and consumer unfamiliarity with cotton products [3][4]. - Steady Medical's commitment to quality over cost has been a cornerstone of its growth, leading to its emergence as a top exporter of medical dressings in China [2][3]. Group 2: Business Model and Strategy - The company operates a dual business model focusing on both medical and consumer products, leveraging the same supply chain and technology standards for synergy [4][5]. - Steady Medical emphasizes innovation and high-quality product development, with a vision of "Cotton Changing the World," and has established itself as a leader in the cotton towel market [4][5]. - The company has invested 2.062 billion yuan in R&D from 2020 to mid-2025, establishing a complete innovation cycle that has contributed to significant revenue growth [5][6]. Group 3: Financial Performance - In the first half of 2025, Steady Medical reported revenues of 5.296 billion yuan, a year-on-year increase of 31.31%, with net profits of 492 million yuan, up 28.07% [5][6]. - The medical segment achieved revenues of 2.52 billion yuan, growing by 46.4%, while Cotton Era generated 2.75 billion yuan, reflecting a 20.3% increase [5][6]. Group 4: Global Expansion and Acquisitions - The company is shifting towards brand export, highlighted by its acquisition of 75.2% of the U.S. medical consumables company GRI for 120 million USD, which is a key step in its globalization strategy [5][6]. - Steady Medical's overseas sales channels generated 1.43 billion yuan in revenue in the first half of 2025, marking an 81.3% increase, with products sold in over 110 countries [6][7]. - The company plans to transition 90% of its overseas medical business to its own brand, moving away from OEM production, while Cotton Era aims to solidify its domestic presence before expanding internationally [6][7].

● 本报记者 张兴旺 从医用敷料到全棉时代创新发展 1989年，李建全辞去湖北省医药保健品进出口公司的"铁饭碗"，南下珠海开启打工生涯。两年后，他怀 揣着"稳稳当当做事，健健康康做人"的理念，将"踏实经营、坚守底线"作为立足的根本，创立了稳健医 疗，从此踏入医用敷料赛道。 2025年，正值稳健医疗登陆A股市场五周年。从1991年李建全创立公司到2009年创办子公司全棉时代， 再到如今成为"医疗+消费品"双轮驱动的大健康龙头企业，稳健医疗凭借对产品质量和长期主义的坚 持，走向世界舞台。 日前，稳健医疗董事长、全棉时代创始人李建全在接受中国证券报记者采访时表示，公司将产品领先和 卓越运营作为战略方向，致力于成为高品质的代名词、消费者信赖的好品牌。当前，公司正加速推动从 产品出海向品牌出海转型，开启全球化新征程。 产品领先是稳健医疗长期坚持的战略，其以创新驱动发展，持续打造高品质产品。在医疗领域，公司坚 持核心基础材料自主研发，重点品类持续迭代升级，确保在产品性能、品质等方面引领市场。在消费品 领域，以"全棉改变世界"为愿景，精选全球优质棉花作为原材料，通过医疗级品质打造差异化消费品； 根据市场洞察快速推出符合消费 ...

Core Insights - The company has transformed from being labeled as a "pandemic beneficiary stock" to a global health platform covering both medical and consumer sectors, demonstrating resilience against industry cyclicality [2][3] - In 2024, the company reported a revenue of 8.978 billion yuan, a year-on-year increase of 9.7%, with core business revenue growth of 18.6% after excluding high-volatility products [3][4] - The company has invested over 1.8 billion yuan in R&D, with a total of 986 patents granted, showcasing its commitment to innovation and technology [2][6][7] Financial Performance - The company has maintained a strong cash flow, returning 3.57 billion yuan to shareholders through dividends and share buybacks since its IPO, exceeding the net proceeds from its initial public offering [4][5] - The company has implemented six cash dividends totaling 2.613 billion yuan and has initiated mid-term dividends in 2024 and 2025, reflecting its financial stability and commitment to shareholder returns [4][5] Product and Market Development - The medical segment has seen significant growth, with high-end dressings and surgical consumables driving revenue, particularly a 193.5% increase in surgical consumables revenue in the first half of 2025 [3][6] - The consumer segment has also performed well, with core products like cotton soft towels and sanitary napkins showing year-on-year revenue growth of 19.5% and 67.6%, respectively [3][6] Technological Advancements - The company has established three R&D centers and a team of 1,360 researchers, focusing on a closed-loop system of basic research, scenario transformation, and brand guidance [6][7] - The company has developed proprietary technologies, such as the all-cotton water-jet non-woven fabric, and has participated in setting national standards, enhancing its industry position [6][7] Global Expansion - The acquisition of GRI Holdings in 2024 marks a shift in the company's global strategy from product export to localized manufacturing, sales, and service [10][11] - The overseas sales channels achieved a revenue of 1.43 billion yuan in the first half of 2025, a year-on-year increase of 81.3%, indicating strong international growth [10][11] Long-term Vision - The company emphasizes sustainable practices, collaborating with research institutions to develop cotton varieties, ensuring a continuous supply of high-quality raw materials [12][13] - The company's evolution reflects a shift from OEM to building its own brand, focusing on quality and social value over short-term profits [13][14]

Core Viewpoint - The article emphasizes the importance of sustainable practices in the cotton industry, highlighting the initiative by All Cotton Era to create a "green win-win chain" through technological innovation and collaboration across the supply chain [1][4]. Group 1: Sustainable Practices - All Cotton Era promotes the environmental value of cotton, advocating for organic cotton usage to reduce chemical fertilizers and pesticides, thereby achieving sustainable cultivation [2][4]. - The company has established three national-level green factories in Hubei, implementing practices that reduce carbon emissions by 5,135 tons annually through low-carbon and zero-carbon technologies [2][5]. - All Cotton Era's core products have received multiple certifications, including China Green Product Certification and Oeko-Tex Certification, underscoring their commitment to sustainability [2][5]. Group 2: Technological Innovation - The company has formed a cotton research institute in collaboration with national laboratories, focusing on breeding new cotton varieties to enhance the material's properties [4][5]. - All Cotton Era has innovated in product development, creating cotton non-woven fabrics and transforming medical-grade gauze into consumer products, significantly improving production efficiency [4][5]. - The integration of technology in manufacturing processes aims to achieve a balance between quality, efficiency, and environmental sustainability [5][6]. Group 3: Economic and Social Impact - The company has sourced over 1 million tons of cotton, benefiting over 6,000 cotton farmers across 100 hectares of farmland [5][6]. - All Cotton Era has sold over 78.6 billion cotton soft towels and has a presence in 6,000 hospitals and 226,000 pharmacies, impacting over 8,000 families [5][6]. - The founder's philosophy of "All Cotton Changes the World" reflects a commitment to sustainable development and positions Chinese cotton as a "green business card" on the global stage [6].

Core Viewpoint - The third China International Supply Chain Promotion Expo showcases the innovative strength and green practices of the cotton industry, with a focus on global sourcing, production, and sales by companies like Steady Medical and Cotton Era [2][3]. Group 1: Event Overview - The expo opened on July 16, featuring Steady Medical and its brand Cotton Era, highlighting the theme "Global Good Cotton, One Cotton One World" [2]. - The event attracted significant attention with immersive experiences such as "Cotton Stories" and real-time connections to production facilities [2][3]. Group 2: Global Production and Market Expansion - The "Global Production" interactive area allowed attendees to witness the transformation of raw cotton into high-quality medical and cotton products [3]. - Steady Medical is expanding its global footprint by investing in production bases in North America and Southeast Asia, while Cotton Era is focusing on the Southeast Asian market and exploring entry into the Middle East and Europe [3]. Group 3: Green Initiatives and Collaborations - A joint initiative called the "Green Win Chain Initiative" was launched, promoting sustainable cooperation in the health sector and enhancing the "green content" of supply chains [3]. - Steady Medical introduced a "Green Operating Room" solution aimed at replacing synthetic materials with cotton, enhancing safety and efficiency in medical settings [4]. Group 4: Technological Innovations - Cotton Era is innovating with core materials like cotton non-woven fabric and gauze, significantly improving production efficiency and expanding applications in daily life [5][6]. - The company’s Cotton Tech continues to push boundaries in softness, breathability, and sustainability, promoting a "cotton lifestyle" as a new choice for comfort and health [6]. Group 5: Future Directions - Both companies aim to deepen their strategies of product leadership, operational excellence, and global vision, positioning Chinese cotton as a "green business card" on the international stage [6].